BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 25001531)

  • 21. Gene therapy targeting hepatocellular carcinoma by a dual-regulated oncolytic adenovirus harboring the focal adhesion kinase shRNA.
    Gao Y; Zhu Y; Huang X; Ai K; Zheng Q; Yuan Z
    Int J Oncol; 2015 Aug; 47(2):668-78. PubMed ID: 26081241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An enhanced anti-tumor effect of apoptin-cecropin B on human hepatoma cells by using bacterial magnetic particle gene delivery system.
    Wang X; Wang JG; Geng YY; Wang JJ; Zhang XM; Yang SS; Jiang W; Liu WQ
    Biochem Biophys Res Commun; 2018 Feb; 496(2):719-725. PubMed ID: 29355529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficient production of an engineered apoptin from chicken anemia virus in a recombinant E. coli for tumor therapeutic applications.
    Lee MS; Sun FC; Huang CH; Lien YY; Feng SH; Lai GH; Lee MS; Chao J; Chen HJ; Tzen JT; Cheng HY
    BMC Biotechnol; 2012 Jun; 12():27. PubMed ID: 22672291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene therapy with apoptin induces regression of xenografted human hepatomas.
    van der Eb MM; Pietersen AM; Speetjens FM; Kuppen PJ; van de Velde CJ; Noteborn MH; Hoeben RC
    Cancer Gene Ther; 2002 Jan; 9(1):53-61. PubMed ID: 11924525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Construction and identification of recombinant adeno-associated virus vector harboring fusion gene NT4-Apoptin-HA2-TAT].
    Wang JS; Zhang MX; Liu DC; Duan XY; Zhou SN; Zhang GJ; Yang GX; Wang QY
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Aug; 24(8):754-6. PubMed ID: 18687210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TAT-apoptin is efficiently delivered and induces apoptosis in cancer cells.
    Guelen L; Paterson H; Gäken J; Meyers M; Farzaneh F; Tavassoli M
    Oncogene; 2004 Feb; 23(5):1153-65. PubMed ID: 14691460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potentiation of a recombinant oncolytic parvovirus by expression of Apoptin.
    Olijslagers S; Dege AY; Dinsart C; Voorhoeve M; Rommelaere J; Noteborn MH; Cornelis JJ
    Cancer Gene Ther; 2001 Dec; 8(12):958-65. PubMed ID: 11781658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AdHu5-apoptin induces G2/M arrest and apoptosis in p53-mutated human gastric cancer SGC-7901 cells.
    Li Q; Zhang H; Tan C; Peng W; Ren G; Jia B; He Y; Wang P; Zhou X; Xiang T
    Tumour Biol; 2013 Dec; 34(6):3569-77. PubMed ID: 23812727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unexpected heat shock element binding ability and tumor-killing activity of the combinatorial function domain of apoptin.
    Zhang L; Yang J; Liu L; Tian W; Gao M; Song W; Ling H; Dong X
    Anticancer Drugs; 2017 Apr; 28(4):401-409. PubMed ID: 28045701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of ceramide metabolism enhances viral protein apoptin's cytotoxicity in prostate cancer.
    Liu X; Elojeimy S; El-Zawahry AM; Holman DH; Bielawska A; Bielawski J; Rubinchik S; Guo GW; Dong JY; Keane T; Hannun YA; Tavassoli M; Norris JS
    Mol Ther; 2006 Nov; 14(5):637-46. PubMed ID: 16887394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor-targeted gene therapy using Adv-AFP-HRPC/IAA prodrug system suppresses growth of hepatoma xenografted in mice.
    Dai M; Liu J; Chen DE; Rao Y; Tang ZJ; Ho WZ; Dong CY
    Cancer Gene Ther; 2012 Feb; 19(2):77-83. PubMed ID: 21959967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined administration of the apoptin gene and poly (I:C) induces potent anti-tumor immune response and inhibits growth of mouse mammary tumors.
    Gupta SK; Tiwari AK; Gandham RK; Sahoo AP
    Int Immunopharmacol; 2016 Jun; 35():163-173. PubMed ID: 27064544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and application of an in vitro apoptin kinase assay.
    Lanz HL; Florea BI; Noteborn MH; Backendorf C
    Anal Biochem; 2012 Feb; 421(1):68-74. PubMed ID: 22080040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy.
    Jakubczak JL; Ryan P; Gorziglia M; Clarke L; Hawkins LK; Hay C; Huang Y; Kaloss M; Marinov A; Phipps S; Pinkstaff A; Shirley P; Skripchenko Y; Stewart D; Forry-Schaudies S; Hallenbeck PL
    Cancer Res; 2003 Apr; 63(7):1490-9. PubMed ID: 12670895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apoptin-modified human mesenchymal stem cells inhibit growth of lung carcinoma in nude mice.
    Du J; Zhang Y; Xu C; Xu X
    Mol Med Rep; 2015 Jul; 12(1):1023-9. PubMed ID: 25816208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonviral gene therapy in vivo with PAM-RG4/apoptin as a potential brain tumor therapeutic.
    An S; Nam K; Choi S; Bai CZ; Lee Y; Park JS
    Int J Nanomedicine; 2013; 8():821-34. PubMed ID: 23589689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Additive cytotoxic effect of apoptin and chemotherapeutic agents paclitaxel and etoposide on human tumour cells.
    Olijslagers SJ; Zhang YH; Backendorf C; Noteborn MH
    Basic Clin Pharmacol Toxicol; 2007 Feb; 100(2):127-31. PubMed ID: 17244262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Augmenting the antitumor effect of TRAIL by SOCS3 with double-regulated replicating oncolytic adenovirus in hepatocellular carcinoma.
    Wei RC; Cao X; Gui JH; Zhou XM; Zhong D; Yan QL; Huang WD; Qian QJ; Zhao FL; Liu XY
    Hum Gene Ther; 2011 Sep; 22(9):1109-19. PubMed ID: 21361790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant Newcastle disease virus Anhinga strain (NDV/Anh-EGFP) for hepatoma therapy.
    Wu Y; Yan S; Lv Z; Chen L; Geng J; He J; Yu Q; Yin J; Ren G; Li D
    Technol Cancer Res Treat; 2014 Apr; 13(2):169-75. PubMed ID: 23819497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiproliferative Effects of Recombinant Apoptin on Lung and Breast Cancer Cell Lines.
    Ezami Razliqi M; Olad G; Dorostkar R; Heydari S; Esmaeili Gouvarchin Ghaleh H
    Arch Iran Med; 2020 Sep; 23(9):593-599. PubMed ID: 32979905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.